Needham Sees Medtronic Poised for Stronger Organic Growth on New Product Wave and Activist-Led Oversight
Needham has upgraded Medtronic to Buy from Hold, arguing that a string of recent and upcoming product introductions across major markets, combined with activist involvement and board-level changes, should help accelerate organic revenue growth and improve execution over the next several years. The firm estimates new offerings could contribute more …